These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
624 related articles for article (PubMed ID: 26702034)
1. Gene therapy: progress and predictions. Collins M; Thrasher A Proc Biol Sci; 2015 Dec; 282(1821):20143003. PubMed ID: 26702034 [TBL] [Abstract][Full Text] [Related]
2. Clinical translation of gene medicine. Wang F; Qin Z; Lu H; He S; Luo J; Jin C; Song X J Gene Med; 2019 Jul; 21(7):e3108. PubMed ID: 31246328 [TBL] [Abstract][Full Text] [Related]
3. Viral-mediated gene transfer for cancer treatment. Wilson DR Curr Pharm Biotechnol; 2002 Jun; 3(2):151-64. PubMed ID: 12022258 [TBL] [Abstract][Full Text] [Related]
4. Non-viral retinal gene therapy: a review. Charbel Issa P; MacLaren RE Clin Exp Ophthalmol; 2012; 40(1):39-47. PubMed ID: 21745262 [TBL] [Abstract][Full Text] [Related]
5. Adeno-associated viral vectors for gene therapy of inherited retinal degenerations. Flannery JG; Visel M Methods Mol Biol; 2013; 935():351-69. PubMed ID: 23150381 [TBL] [Abstract][Full Text] [Related]
6. AAV vectors for hemophilia B gene therapy. Chao H; Walsh CE Mt Sinai J Med; 2004 Oct; 71(5):305-13. PubMed ID: 15543431 [TBL] [Abstract][Full Text] [Related]
7. The gene therapy journey for hemophilia: are we there yet? High KA Hematology Am Soc Hematol Educ Program; 2012; 2012():375-81. PubMed ID: 23233607 [TBL] [Abstract][Full Text] [Related]
8. Micro-RNA in disease and gene therapy. Lundstrom K Curr Drug Discov Technol; 2011 Jun; 8(2):76-86. PubMed ID: 21513487 [TBL] [Abstract][Full Text] [Related]
9. Gene therapy for haemophilia "A" and "B": efficacy, safety and immune consequences. Chuah MK; Vandendriessche T Bull Mem Acad R Med Belg; 2007; 162(5-6):357-61. PubMed ID: 18405006 [TBL] [Abstract][Full Text] [Related]
10. Intravitreal Implantation of Genetically Modified Autologous Bone Marrow-Derived Stem Cells for Treating Retinal Disorders. Tracy CJ; Sanders DN; Bryan JN; Jensen CA; Castaner LJ; Kirk MD; Katz ML Adv Exp Med Biol; 2016; 854():571-7. PubMed ID: 26427461 [TBL] [Abstract][Full Text] [Related]
12. Vectors and strategies for nonviral cancer gene therapy. Pahle J; Walther W Expert Opin Biol Ther; 2016; 16(4):443-61. PubMed ID: 26761200 [TBL] [Abstract][Full Text] [Related]
13. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia. High KA Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929 [TBL] [Abstract][Full Text] [Related]
14. Vector-mediated cancer gene therapy: an overview. Seth P Cancer Biol Ther; 2005 May; 4(5):512-7. PubMed ID: 15908802 [TBL] [Abstract][Full Text] [Related]
15. Applications of Virus Vector-Mediated Gene Therapy in China. Lin Q; Wang DG; Zhang ZQ; Liu DP Hum Gene Ther; 2018 Feb; 29(2):98-109. PubMed ID: 29284296 [TBL] [Abstract][Full Text] [Related]
16. The Future Looks Brighter After 25 Years of Retinal Gene Therapy. Auricchio A; Smith AJ; Ali RR Hum Gene Ther; 2017 Nov; 28(11):982-987. PubMed ID: 28825330 [TBL] [Abstract][Full Text] [Related]
18. Viral vectors in cancer immunotherapy: which vector for which strategy? Collins SA; Guinn BA; Harrison PT; Scallan MF; O'Sullivan GC; Tangney M Curr Gene Ther; 2008 Apr; 8(2):66-78. PubMed ID: 18393828 [TBL] [Abstract][Full Text] [Related]
19. Nanoparticles as Delivery Vehicles for the Treatment of Retinal Degenerative Diseases. Wang Y; Rajala A; Rajala RVS Adv Exp Med Biol; 2018; 1074():117-123. PubMed ID: 29721935 [TBL] [Abstract][Full Text] [Related]
20. Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia. Monahan PE; Samulski RJ; Tazelaar J; Xiao X; Nichols TC; Bellinger DA; Read MS; Walsh CE Gene Ther; 1998 Jan; 5(1):40-9. PubMed ID: 9536263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]